Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 HKD | -4.03% | +19.97% | +7.04% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.04% | 661M | |
+26.59% | 681B | |
+20.93% | 556B | |
-5.30% | 361B | |
+17.14% | 325B | |
+4.93% | 285B | |
+13.55% | 235B | |
+3.92% | 199B | |
-11.57% | 189B | |
-3.89% | 157B |
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics
- Ocumension Therapeutics : Snaps Up Interests In Two Eye Drugs In China From Novartis